BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. - Current Ratioverified

BBIO

Price:

$66.27

Market Cap:

$12.98B

BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions. The firm boasts an extensive portfolio comprising 30 distinct development initiatives, spanning the entire spectrum from initial discovery research to advanced clinical trial phases. Notable candidates within its development pipeline include: AG10 and BBP-265: A small molecule designed to stabilize transthyretin (TTR), currently in a pivotal Phase 3 clinical trial targeting transthyretin amyloidosis-cardiomyopathy (ATTR-CM). BBP-831: A selective small molecule inhibitor of FGFR1-3, which is undergoing Phase 2 clinical evaluation for treating ...[Read more]

Industry

Biotechnology

IPO Date

2019-06-27

Stock Exchange

NASDAQ

Ticker

BBIO

The Current Ratio as of June 2026 (TTM) for BridgeBio Pharma, Inc. (BBIO) is 1.44

According to BridgeBio Pharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.44. This represents a change of -56.00% compared to the average of 3.28 of the last 4 quarters.

BridgeBio Pharma, Inc. (BBIO) Historical Current Ratio (quarterly & annually)

How has BBIO Current Ratio performed in the past?

The mean historical Current Ratio of BridgeBio Pharma, Inc. over the last ten years is 6.99. The current 1.44 Current Ratio has changed 1.97% with respect to the historical average. Over the past ten years (40 quarters), BBIO's Current Ratio was at its highest in in the March 2020 quarter at 14.25. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

6.99

Median

6.58

Minimum

2.62

Maximum

13.67

BridgeBio Pharma, Inc. (BBIO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BridgeBio Pharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 40.58%

Maximum Annual Current Ratio = 13.67

Minimum Annual Increase = -43.93%

Minimum Annual Current Ratio = 2.62

Quarterly (TTM)
Annual
YearCurrent RatioChange
20252.62-43.93%
20244.6740.58%
20233.32-26.54%
20224.52-31.32%
20216.58-2.08%
20206.72-28.63%
20199.42-31.10%
201813.6720.30%

BridgeBio Pharma, Inc. (BBIO) Average Current Ratio

How has BBIO Current Ratio performed in the past?

The current Current Ratio of BridgeBio Pharma, Inc. (BBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.54

5-year avg

4.34

10-year avg

6.99

BridgeBio Pharma, Inc. (BBIO) Current Ratio vs. Peers

How is BBIO’s Current Ratio compared to its peers?

BridgeBio Pharma, Inc.’s Current Ratio is less than Revolution Medicines, Inc. (6.80), less than Ionis Pharmaceuticals, Inc. (4.10), greater than Ascendis Pharma A/S (1.00), less than Summit Therapeutics Inc. (7.41), less than Roivant Sciences Ltd. (18.37), less than Moderna, Inc. (2.41), less than BioMarin Pharmaceutical Inc. (5.81), less than Exelixis, Inc. (3.26), less than Atrium Therapeutics, Inc. (13.04), less than Jazz Pharmaceuticals plc (2.04),

Build a custom stock screener for BridgeBio Pharma, Inc. (BBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BridgeBio Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BridgeBio Pharma, Inc. (BBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BridgeBio Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is BridgeBio Pharma, Inc.'s Current Ratio?

How is the Current Ratio calculated for BridgeBio Pharma, Inc. (BBIO)?

What is the highest Current Ratio for BridgeBio Pharma, Inc. (BBIO)?

What is the 3-year average Current Ratio for BridgeBio Pharma, Inc. (BBIO)?

What is the 5-year average Current Ratio for BridgeBio Pharma, Inc. (BBIO)?

How does the current Current Ratio for BridgeBio Pharma, Inc. (BBIO) compare to its historical average?